Meridian Bioscience Inc: Device Recall

Recall #Z-1019-2026 · 12/05/2025

Class II: Risk

Recall Details

Recall Number
Z-1019-2026
Classification
Class II
Product Type
Device
Recalling Firm
Meridian Bioscience Inc
Status
Ongoing
Date Initiated
12/05/2025
Location
Cincinnati, OH, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
211 units

Reason for Recall

The affected lots show a decline in performance over time, which may lead to false-negative results.

Product Description

Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300

Distribution Pattern

US Nationwide distribution and the OUS country of Italy.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.